Sofar S.p.a.

Naturewohl Pharma Gmbh

Mr. Giuseppe Maria Ricchiuto

Simone Guglielmetti

Andrea Biffi

Walter Fiore

Ruggero Rossi

Diego Mora

Giuseppe Maria Ricchiuto

Claudio Sebastiano Gardana

Silvia Balzaretti

The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.

Exopolysaccharides and uses thereof

The present invention provides a strain ofor mutant or variant thereof showing at least an adhesion of about 10 bacterial cells per mm2 of epithelial cell monolayer or having at least an adhesion index of 1.5 and a strain ofor mutant or variant thereof beingMIMBb75, deposited under deposit No. DSM 24514, or a mutant or variant thereof for use as probiotic, in foodstuff and/or as a medicament. Further provided is a probiotic for mulation, comprising any of the strains, mutants or variants mentioned above, uses of said probiotic formulation, strains, mutants and variants thereof and a method for producing said probiotic formulation.

Bifidobacterium bifidum strains for application in gastrointestinal diseases

The present disclosure relates to a process for pre-treating rawcomprising at least one allergenic activity substance, which comprises reactingwith a probiotic microorganism containing one or more cinnamoyl-esterase activity enzymes to obtain a semisolidderivative substantially without or impoverished of allergenic substances. The present invention also relates to a method of purifying semisolidderivative to obtain a hydroalcoholic hydrodispersiblederivative.

Process for obtaining non-allergic propolis

Growing community of inventors

Milan, Italy

Simone Guglielmetti